121 related articles for article (PubMed ID: 4394676)
1. Strength of H-2 and non-H-2 antigens as compared in ALS-suppressed recipients.
Hilgert I; Nouza K
Folia Biol (Praha); 1970; 16(6):369-73. PubMed ID: 4394676
[No Abstract] [Full Text] [Related]
2. Influence of the properties of skin allografts on the "graft survival promoting effect" of antilymphocyte serum.
Nouza K; Nêmec M; Viklický V; Novotný J
Folia Biol (Praha); 1976; 22(2):74-81. PubMed ID: 6347
[TBL] [Abstract][Full Text] [Related]
3. Prolonged administration of antithymocyte serum in mice. I. Observations on cellular and humoral immunity.
Nehlsen SL
Clin Exp Immunol; 1971 Jul; 9(1):63-77. PubMed ID: 4397709
[TBL] [Abstract][Full Text] [Related]
4. [Effect of phytohemagglutinin and antilymphocyte serum on the survival time of homologous skin grafts in mice].
Kaden J; Kaden K
Z Exp Chir; 1973; 6(6):401-9. PubMed ID: 4152194
[No Abstract] [Full Text] [Related]
5. Relative strength of the male-specific antigen.
Polácková M; Rejzková J; Viklický V
Folia Biol (Praha); 1970; 16(6):381-4. PubMed ID: 4394678
[No Abstract] [Full Text] [Related]
6. Possible role of serum factors in non-H-2 allograft response in mice.
Nĕmec M; Nouza K
Folia Biol (Praha); 1974; 20(1):75-8. PubMed ID: 4154874
[No Abstract] [Full Text] [Related]
7. Tolerance to skin allografts by immunosuppressive "pulse" of methylhydrazine derivatives and antilymphocyte serum.
Floersheim GL; Brune K
Transplant Proc; 1971 Mar; 3(1):688-92. PubMed ID: 4398510
[No Abstract] [Full Text] [Related]
8. [Prevention of the graft vs host reaction in rats by means of allogeneic antilymphocyte serum following bone marrow transplantation].
Jeannet M; Vaucher A; Gervasoni C
Schweiz Med Wochenschr; 1972 Nov; 102(44):1598-600. PubMed ID: 4405059
[No Abstract] [Full Text] [Related]
9. Treatment and pretreatment of graft-versus-host reaction by antilymphocyte serum.
Haskovcová H; Nouza K
Folia Biol (Praha); 1970; 16(6):397-406. PubMed ID: 4395162
[No Abstract] [Full Text] [Related]
10. Different sensitivity of H-2K and H-2D incompatibility to ALS immunosuppression.
Démant P; Nouza K
Folia Biol (Praha); 1971; 17(6):410-3. PubMed ID: 4400221
[No Abstract] [Full Text] [Related]
11. Mode of action of antilymphocyte sra (ALS).
Harris NS; Merino GE; Najarian JS
Transplant Proc; 1971 Mar; 3(1):797-9. PubMed ID: 4398511
[No Abstract] [Full Text] [Related]
12. Use of low doses of homozygous allogeneic bone marrow cells to induce tolerance with antilymphocyte serum (ALS): tolerance by intraorgan injection.
Monaco AP; Gozzo JJ; Wood ML; Liegeois A
Transplant Proc; 1971 Mar; 3(1):680-3. PubMed ID: 4398509
[No Abstract] [Full Text] [Related]
13. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing.
Wood ML; Monaco AP; Gozzo JJ; Liegeois A
Transplant Proc; 1971 Mar; 3(1):676-9. PubMed ID: 4398508
[No Abstract] [Full Text] [Related]
14. Reduction of GvH splenomegaly in mice by antilymphocyte serum (ALS): correlation of the effect with immunosuppressive potency of ALS.
Mazuran R; Volić B; Silobrcić V
Z Immunitatsforsch Exp Klin Immunol; 1974 Sep; 147(4):378-83. PubMed ID: 4157053
[No Abstract] [Full Text] [Related]
15. Immunosuppression, virus and oncogenesis in mice.
Nehlsen SL
Transplant Proc; 1971 Mar; 3(1):811-3. PubMed ID: 4106340
[No Abstract] [Full Text] [Related]
16. Immunocompetence in regional graft-versus-host reaction of blood cells from skin allografted or ALS treated rats.
Hasková V; Gansová E; Hajná I
Folia Biol (Praha); 1973; 19(4):261-6. PubMed ID: 4148073
[No Abstract] [Full Text] [Related]
17. Studies on time-dependence of immunosuppressive effects of antilymphocyte serum in vivo and in vitro.
Nouza K; Haskovcova H; Sejkorova J; Nemec M
Transplant Proc; 1971 Mar; 3(1):803-6. PubMed ID: 4398513
[No Abstract] [Full Text] [Related]
18. Indirect evidence of two adverse components of the humoral response to skin allografts as revealed in ALS-suppressed mice.
Nouza K; Hilgert I; Nĕmec M; Kristofová H
Folia Biol (Praha); 1972; 18(4):264-9. PubMed ID: 4559929
[No Abstract] [Full Text] [Related]
19. [Cellular immunity in actively conditioned recipients of renal allotransplants (author's transl)].
Haefen UV; Garovoy MR; Wren SF; Martins AC; Wilson RE
Dtsch Med Wochenschr; 1975 Feb; 100(8):370-2. PubMed ID: 234839
[TBL] [Abstract][Full Text] [Related]
20. Heterologous antilymphocyte serum: a review.
Jeejeebhoy HF
Can J Surg; 1971 Jan; 14(1):5-18. PubMed ID: 4395651
[No Abstract] [Full Text] [Related]
[Next] [New Search]
